Home » News » News » Executive Spotlight: Mickey Urdea, Ph.D., Chairman, CEO and Founder of Tethys Bioscience
Executive Spotlight: Mickey Urdea, Ph.D., Chairman, CEO and Founder of Tethys Bioscience
Submitted on:
09.17.2009
CHI's Nicole Beckstrand spoke with Mickey Urdea, Ph.D., co-founder, chairman and CEO of
Tethys Bioscience
, for the Executive Spotlight on CHI's blog. Udea is a true
Renaissance man
, with interests not just in improving medical care through early detection and prevention of chronic diseases, but in raising carniverous plants and learning about classical music. In the early 1980s Urdea was one of the first employees at Chiron where he directed the nucleic acids chemistry group and began the molecular diagnostics efforts. He led the development of quantitative RNA and DNA assays, including the introduction of the first HIV and HCV viral load tests. He became head of the Nucleic Acid Diagnostics business unit at Chiron. In 1998, he joined Bayer Diagnostics as senior vice president of Nucleic Acid Diagnostics and acting-chief scientific officer of Bayer Diagnostics. He left Bayer in 2000 and co-founded Tethys Bioscience in 2002. Urdea received his doctorate in biochemistry at Washington State University and held a National Institutes of Health postdoctoral fellowship at the University
of California San Francisco
with
William J. Rutter
.
Click here to read the full interview on CHI's Blog.
CHI-Advancing California biomedical research and innovation
Back to News Items